WFG Advisors’s Celldex Therapeutics CLDX Stock Holding History

WFG Advisors’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1K	Hold	33	–	–	﹤0.01%	1471
2017 Q1	$2K	Hold	33	–	–	﹤0.01%	1331
2016 Q4	$2K	Hold	33	–	–	﹤0.01%	1404
2016 Q3	$2K	Hold	33	–	–	﹤0.01%	1388
2016 Q2	$2K	Hold	33	–	–	﹤0.01%	1367
2016 Q1	$2K	Hold	33	–	–	﹤0.01%	1327
2015 Q4	$8K	Hold	33	–	–	﹤0.01%	1122
2015 Q3	$5K	Hold	33	–	–	﹤0.01%	1248
2015 Q2	$13K	Hold	33	–	–	﹤0.01%	1104
2015 Q1	$14K	Hold	33	–	–	﹤0.01%	1091
2014 Q4	$9K	Hold	33	–	–	﹤0.01%	1491
2014 Q3	$6K	Buy	33 +13	+65%	+$2.83K	﹤0.01%	1611
2014 Q2	$5K	Hold	20	–	–	﹤0.01%	1648
2014 Q1	$5K	Buy	+20	New	+$7.66K	﹤0.01%	1612

Other funds holding CLDX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

KLP Enterprises Branford, Connecticut $1.97M AUM

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return